Bank of New York Mellon »

Arrivent Biopharma shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Arrivent Biopharma shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $406k 23k 17.86

More positions owned by Bank of New York Mellon

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl A Cap (GOOGL)
Alphabet Inc-cl C Cap (GOOG)
Ishares Core S&p 500 Etf Core (IVV)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Mastercard Inc - A Cl A (MA)
Exxon Mobil Corporation (XOM)
UnitedHealth (UNH)

View all positions for Bank of New York Mellon

Top funds holding Arrivent Biopharma

OrbiMed Advisors
FMR
Octagon Capital Advisors
Sofinnova Ventures
Suvretta Capital Management
General Catalyst Group Management
Sc China Holding
BlackRock
Vanguard Group
Cormorant Asset Management
Perceptive Advisors
Citadel Advisors
Geode Capital Management
Millennium Management
Farallon Capital Management

View all funds holding Arrivent Biopharma